Know Cancer

or
forgot password

Präklinische Studie Zur Etablierung Einer Immuntherapie für Das Nebennierenrindenkarzinom - Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma


Phase 0
18 Years
N/A
Open (Enrolling)
Both
Adrenocortical Carcinoma, Cushing's Syndrome

Thank you

Trial Information

Präklinische Studie Zur Etablierung Einer Immuntherapie für Das Nebennierenrindenkarzinom - Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma


Inclusion Criteria:



- patients with histological proven adrenocortical carcinoma

- healthy persons as control group

- Life expectancy > 6 months

Exclusion Criteria:

- autoimmune diseases

- severe clinical condition

Type of Study:

Observational [Patient Registry]

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Outcome Measure:

To find reasonable antigens for a vaccination therapy in ACC

Principal Investigator

Martin Fassnacht, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Wuerzburg

Authority:

Germany: Ethics Commission

Study ID:

Wue-Immuno-ACC-83/05

NCT ID:

NCT00457587

Start Date:

September 2005

Completion Date:

December 2013

Related Keywords:

  • Adrenocortical Carcinoma
  • Cushing's Syndrome
  • Carcinoma
  • Cushing Syndrome
  • Adrenocortical Carcinoma

Name

Location